Prabhdeep Singh - 16 Sep 2022 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: Chief Growth Officer
Signature: /s/ Joseph R. Martin, as Attorney-in-Fact
Issuer symbol: CLOV
Transactions as of: 16 Sep 2022
Net transactions value: $0
Form type: 4
Filing time: 20 Sep 2022, 16:36:18 UTC
Previous filing: 16 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Award	$0	+353,356	+68%	$0.000000	872,821	16 Sep 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of September 16, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of September 16, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

Content

Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of September 16, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of September 16, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

Remarks:

Exhibit List 24.1- Power of Attorney